Tanger Releases FY24 Earnings Guidance
| BIVRX Fund | USD 17.16 0.25 1.48% |
Slightly above 52% of Balter Invenomic's investors are presently thinking to get in. The analysis of overall sentiment of trading Balter Invenomic Fund mutual fund suggests that some investors are interested at this time. Balter Invenomic's investing sentiment can be driven by a variety of factors including economic data, Balter Invenomic's earnings reports, geopolitical events, and overall market trends.
Balter |
Tanger issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 2.09-2.13 for the period, compared to the consensus estimate of 2.10. Tanger also updated its FY 2024 guidance to 2.090-2.130 EPS. Tanger Price Performance Tanger stock traded up 0.10
Read at thelincolnianonline.com
 |
Balter Invenomic Fundamental Analysis
We analyze Balter Invenomic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Balter Invenomic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Balter Invenomic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Balter Invenomic is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Balter Invenomic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Balter Invenomic mutual fund to make a market-neutral strategy. Peer analysis of Balter Invenomic could also be used in its relative valuation, which is a method of valuing Balter Invenomic by comparing valuation metrics with similar companies.
Peers
Balter Invenomic Related Equities
| NEITX | Nebraska Municipal | 0.32 | ||||
| OKMUX | Oklahoma Municipal | 0.28 | ||||
| BXDYX | Barings Active | 0.22 | ||||
| PATFX | T Rowe | 0.18 | ||||
| MGGNX | Mirova Global | 0.11 | ||||
| MDMTX | Blrc Sgy | 0.09 | ||||
| TTRBX | Ambrus Core | 0.10 | ||||
| BSGAX | Sterling Capital | 0.12 |
Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |